Abstract
Contact lens type amniotic membrane (CLAM) is a promising new approach to using amniotic membrane in ophthalmology. It can be used to treat a range of ocular surface disorders, including dry eye disease, corneal ulcers, and chemical burns. CLAM can help to reduce inflammation, promote epithelialization and wound healing, and improve corneal clarity and vision. Its ease of handling and application, combined with its potential therapeutic benefits, make it an attractive option for treating a range of ocular surface diseases. However, further studies are needed to fully evaluate the safety and efficacy of CLAM, and to optimize its processing and application protocols.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
